|

Mesenchymal Stromal Cells (MSC) Dose Level 1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Wisconsin, Madison1

Indications

  • Sjogren's Disease1
  • Xerostomia1
  • Graft-versus-host-disease1
  • Arthritis1

Madison, Wisconsin1 trial

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

University of Wisconsin

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.